What is Azelis?
Founded in 2001 through the merger of Novorchem and Arnaud, Azelis has evolved into a leading international player in the distribution of specialty chemicals and food ingredients. The company operates across more than 65 countries, serving approximately 62,000 customers with a portfolio of over 35,000 products. Azelis is structured into two primary divisions: Life Sciences, encompassing sectors like Personal Care, Pharma, and Food & Nutrition; and Industrial Chemicals, which includes Coatings, Adhesives, Sealants, and Elastomers, among other industrial applications. With a global network of over 70 application laboratories, Azelis provides crucial formulation development and technical guidance, reinforcing its role as an innovation service provider.
How much funding has Azelis raised?
Azelis has raised a total of $1B across 1 funding round:
Stock Offering
$1B
Stock Issuance/Offering (2021): $1B, investors not publicly disclosed
What's next for Azelis?
The recent major strategic investment in Azelis is poised to fuel further global expansion and enhance its innovation capabilities. As a publicly traded entity on Euronext Brussels, the company is well-positioned to leverage this capital for strategic acquisitions, R&D initiatives, and strengthening its market presence in key regions. Azelis's commitment to sustainable business solutions and its entrepreneurial approach suggest a continued focus on value creation for its principals and customers, aiming to solidify its leadership in the specialty chemicals and food ingredients distribution sector.
See full Azelis company page
